AstraZeneca Competitors

Stocks Brazil . 
Stock . AstraZeneca PLC
A1ZN34 Stock  BRL 64.20  0.27  0.42%   
AstraZeneca PLC competes with MAHLE Metal, Livetech, Monster Beverage, Unifique Telecomunicaes, and Zoom Video; as well as few others. The company operates under Healthcare sector and is part of Drug Manufacturers-General industry. Analyzing AstraZeneca PLC competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of AstraZeneca PLC to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out AstraZeneca PLC Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of AstraZeneca PLC competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
61.7964.2066.61
Details
Intrinsic
Valuation
LowRealHigh
54.5056.9170.62
Details
Naive
Forecast
LowNextHigh
66.6969.1071.51
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
57.4866.1574.82
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AstraZeneca PLC. Your research has to be compared to or analyzed against AstraZeneca PLC's peers to derive any actionable benefits. When done correctly, AstraZeneca PLC's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AstraZeneca PLC.

AstraZeneca PLC Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between AstraZeneca PLC and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of AstraZeneca and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of AstraZeneca PLC does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
Z1OM34
+ 0.93
M2RV34
M2RV34
+ 0.89
M1NS34
Z1OM34
+ 0.82
M1NS34
LVTC3
+ 0.7
LEVE3
TECN3
+ 0.47
M2RV34
TECN3
+ 0.47
Z1OM34
  
High negative correlations   
Z1OM34
- 0.86
LVTC3
M2RV34
- 0.84
LVTC3
Z1OM34
- 0.74
LEVE3
M1NS34
- 0.72
LEVE3
M2RV34
- 0.7
LEVE3
M1NS34
- 0.66
LVTC3

Risk-Adjusted Indicators

There is a big difference between AstraZeneca Stock performing well and AstraZeneca PLC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AstraZeneca PLC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

AstraZeneca PLC Competitive Analysis

The better you understand AstraZeneca PLC competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, AstraZeneca PLC's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across AstraZeneca PLC's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
A1ZN34 LEVE3 LVTC3 M1NS34 FIQE3 M2RV34 Z1OM34 TECN3
 0.42 
 64.20 
AstraZeneca
 1.06 
 27.16 
MAHLE
 0.94 
 3.17 
Livetech
 1.86 
 40.46 
Monster
 0.50 
 3.95 
Unifique
 0.56 
 53.55 
Marvell
 1.95 
 20.08 
Zoom
 3.45 
 5.60 
Technos
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Moderately volatile
Very steady
Slightly risky
Very steady
Not too volatile
Slightly risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Good
Insignificant
Good
Good
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Low
Low
Unknown
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Under Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Hold
Hold
Hold
Strong Sell
Hold
Strong Sell
Hold
Current Ratio
N/A
2.05 X
N/A
4.45 X
N/A
3.49 X
3.22 X
Net Asset
105.36 B
2.94 B
1.49 B
7.8 B
1.62 B
7.55 B
642.73 M
Profit Margin
0.07 %
0.14 %
0.04 %
0.19 %
0.19 %
0.16 %
0.10 %
EBITDA
7.54 B
832.02 M
284.59 M
1.85 B
242.74 M
1.11 B
56.69 M
Operating Margin
0.19 %
0.14 %
0.10 %
0.26 %
0.25 %
0.16 %
0.17 %
Current Valuation
1.25 T
3.94 B
790.17 M
259.19 B
1.09 B
86.53 B
200.74 M
Price To Book
3.09 X
2.32 X
0.54 X
7.73 X
1.31 X
3.65 X
0.45 X
Five Year Return
N/A
4.84 %
N/A
N/A
N/A
N/A
N/A
Retained Earnings
N/A
N/A
N/A
N/A
N/A
N/A
191 M
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
465 M
Beta
0.19
1.01
N/A
0.88
N/A
-0.23
1.57
Number Of Employees
10
7.39 K
315
3.46 K
1.57 K
8.42 K
15
Shares Outstanding
9.3 B
128.31 M
63.73 M
4.18 B
353.05 M
7.31 B
73.53 M
Cash Flow From Operations
5.96 B
357.9 M
(29.55 M)
1.16 B
171.58 M
1.61 B
42.46 M
Annual Yield
0.02 %
0.05 %
0.02 %
N/A
0.05 %
N/A
0.04 %
Total Debt
28.13 B
100.07 M
270.7 M
20.77 M
238.98 M
102.91 M
123.67 M
Return On Equity
0.0863
0.34
0.0726
0.19
0.12
0.13
0.11
Z Score
24.0
28.0
0.6
N/A
2.4
N/A
0.6
Return On Asset
0.0531
0.12
0.0421
0.13
0.0571
0.0586
0.058
Book Value Per Share
11.96 X
12.84 X
10.16 X
1.63 X
2.82 X
19.69 X
4.72 X
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
128 M
Total Asset
105.36 B
2.94 B
1.49 B
7.8 B
1.62 B
7.55 B
642.73 M
Last Dividend Paid
2.9
3.66
0.17
N/A
0.084
N/A
0.081
Debt To Equity
N/A
0.14 %
N/A
0 %
N/A
0.02 %
18.40 %
Target Price
N/A
27.0
6.0
N/A
6.13
N/A
5.0
Shares Owned By Institutions
N/A
14.88 %
53.24 %
0.01 %
14.05 %
N/A
22.47 %
Market Capitalization
1.13 T
4.51 B
457.56 M
283.94 B
1.05 B
116.53 B
173.54 M
Price To Earnings To Growth
0.68 X
2.74 X
N/A
3.42 X
N/A
N/A
N/A
Price To Earning
N/A
9.96 X
N/A
4.51 X
N/A
3.89 X
10.32 X
Price To Sales
25.25 X
0.88 X
0.35 X
44.41 X
2.12 X
25.43 X
0.46 X
Net Income
112 M
566.86 M
72.45 M
1.38 B
80.54 M
1.38 B
28.08 M
Earnings Per Share
1.85 X
4.47 X
0.49 X
1.49 X
0.24 X
0.44 X
0.43 X
Shares Owned By Insiders
N/A
7.00 %
35.47 %
N/A
72.33 %
N/A
40.67 %
Revenue
37.42 B
3.62 B
1.07 B
5.54 B
457.98 M
4.1 B
314.4 M
Working Capital
N/A
N/A
N/A
N/A
N/A
N/A
337 M
Cash And Equivalents
N/A
317.66 M
38.47 M
2.55 B
524.53 M
4.69 B
N/A
Cash Per Share
N/A
1.92 X
N/A
0.60 X
N/A
15.92 X
0.61 X
Gross Profit
35.73 B
986.96 M
294.86 M
3.11 B
224.89 M
3.05 B
165.18 M
Day Typical Price
64.3
27.24
3.19
40.34
3.96
53.03
20.02
5.68
Accumulation Distribution
0.0047
16219.91
113.31
0.84
10113.86
35.86
367.74
3804.44
Market Facilitation Index
0.3
0.0
0.0
0.0036
0.0
0.0015
1.0E-4
0.0
Daily Balance Of Power
(0.90)
(0.33)
(0.50)
2.114286
(0.13)
(0.18)
(0.41)
(0.77)
Period Momentum Indicator
(0.27)
(0.29)
(0.03)
0.74
(0.02)
(0.30)
(0.40)
(0.20)
Rate Of Daily Change
1.0
0.99
0.99
1.02
0.99
0.99
0.98
0.97
Day Median Price
64.35
27.29
3.2
40.28
3.97
52.77
19.99
5.72
Price Action Indicator
(0.28)
(0.27)
(0.04)
0.55
(0.03)
0.63
(0.11)
(0.22)
Relative Strength Index
42.27
33.72
33.73
51.84
52.64
79.2
87.75
72.43
Coefficient Of Variation
(815.53)
(743.97)
(1,013)
500.57
19763.13
496.48
512.43
5318.79
Mean Deviation
1.62
0.8623
2.02
1.32
1.45
1.79
1.74
2.2
Jensen Alpha
(0.31)
(0.22)
(0.36)
0.3189
(0.07)
0.4888
0.4722
0.0521
Total Risk Alpha
(0.68)
(0.38)
(0.69)
0.0623
(0.33)
0.1002
0.0813
(0.42)
Sortino Ratio
N/A
N/A
N/A
0.1217
(0.04)
0.1359
0.146
(0.03)
Downside Variance
N/A
N/A
N/A
3.02
7.1
7.63
5.52
6.6
Standard Deviation
2.38
1.27
2.65
1.71
2.1
2.51
2.43
2.95
Kurtosis
3.25
3.85
1.74
1.21
3.05
1.08
1.1
0.7283
Potential Upside
2.42
1.96
3.61
2.83
2.64
5.43
4.92
6.13
Treynor Ratio
(11.62)
(0.52)
(0.38)
3.07
0.0011
8.62
(6.47)
(0.84)
Maximum Drawdown
14.89
7.84
12.92
9.83
11.45
11.71
12.05
13.33
Variance
5.68
1.61
7.01
2.93
4.42
6.3
5.89
8.72
Market Risk Adjusted Performance
(11.61)
(0.51)
(0.37)
3.08
0.0111
8.63
(6.46)
(0.83)
Risk Adjusted Performance
(0.09)
(0.1)
(0.07)
0.1583
0.0102
0.1609
0.156
0.0218
Skewness
(1.03)
(0.67)
0.9589
(0.41)
(0.88)
0.2698
0.2353
0.7056
Semi Deviation
N/A
N/A
N/A
1.37
2.31
1.82
1.69
2.38
Information Ratio
(0.18)
(0.24)
(0.15)
0.1236
(0.06)
0.1495
0.1414
(0.03)
Value At Risk
(4.73)
(1.78)
(3.99)
(2.38)
(3.50)
(3.34)
(3.46)
(3.91)
Expected Short fall
N/A
N/A
N/A
(1.62)
(1.46)
(1.80)
(2.06)
(2.74)
Downside Deviation
N/A
N/A
N/A
1.74
2.66
2.76
2.35
2.57
Semi Variance
N/A
N/A
N/A
1.87
5.31
3.31
2.87
5.68

AstraZeneca PLC Competition Performance Charts

Five steps to successful analysis of AstraZeneca PLC Competition

AstraZeneca PLC's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by AstraZeneca PLC in relation to its competition. AstraZeneca PLC's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of AstraZeneca PLC in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact AstraZeneca PLC's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to AstraZeneca PLC, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your AstraZeneca PLC position

In addition to having AstraZeneca PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Automobiles and Trucks Thematic Idea Now

Automobiles and Trucks
Automobiles and Trucks Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Automobiles and Trucks theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Automobiles and Trucks Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in AstraZeneca Stock

AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY